M
Martin Roderfeld
Researcher at University of Giessen
Publications - 79
Citations - 2225
Martin Roderfeld is an academic researcher from University of Giessen. The author has contributed to research in topics: Fibrosis & Schistosoma mansoni. The author has an hindex of 23, co-authored 58 publications receiving 1934 citations. Previous affiliations of Martin Roderfeld include RWTH Aachen University & University of Marburg.
Papers
More filters
Journal ArticleDOI
Expression of MMPs and TIMPs in liver fibrosis – a systematic review with special emphasis on anti-fibrotic strategies
TL;DR: The current knowledge of the pathophysiology of liver fibrogenesis with special emphasis on MMPs and TIMPs is presented and the content is summarized in a table.
Journal ArticleDOI
Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.
Javier Redondo-Muñoz,Estefania Ugarte-Berzal,María José Terol,Philippe E. Van den Steen,Mercedes Hernández del Cerro,Martin Roderfeld,Elke Roeb,Ghislain Opdenakker,José A. García-Marco,Angeles García-Pardo +9 more
TL;DR: It is established that MMP/receptor binding induces intracellular survival signals and highlight the role of (pro)MMP-9 in B-CLL pathogenesis.
Journal ArticleDOI
Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice.
Rebeca Salguero Palacios,Martin Roderfeld,S. Hemmann,Timo Rath,Srebrena Atanasova,Annette Tschuschner,Olav A. Gressner,Ralf Weiskirchen,Jürgen Graf,Elke Roeb +9 more
TL;DR: TAA in drinking water is an effective and elegant model to induce reproducible states of liver fibrosis without parenchymal damage in mice and is demonstrated for the first time that transiently increased activation patterns of HSC are observed in toxically induced hepatic fibrosis.
Journal ArticleDOI
Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice
Martin Roderfeld,Ralf Weiskirchen,Sandra Wagner,Marie-Luise Berres,Corinna Henkel,Joachim Grötzinger,Axel M. Gressner,Siegfried Matern,Elke Roeb,Elke Roeb +9 more
TL;DR: Application of MMP‐9 mutants as TIMP‐1 scavengers may provide a new therapeutic strategy for hepatic fibrosis based on the assignment of inactivated enzymes acting as scavengers for TIMP•1.
Journal ArticleDOI
Matrix metalloproteinase functions in hepatic injury and fibrosis.
TL;DR: The current review aims to summarize and update the knowledge about expression pattern and the central roles of MMPs in hepatic fibrosis.